C12N 2760/18533
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2760/18533 (Use of viral protein as therapeutic agent other than vaccine) appears on 4 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 9
- Assignees
- 6
- Inventors
- 17
- Latest grant
- 3 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Conformational epitopes in respiratory syncytial virus G protein central conserved region3 Oct 2023US 11,773,143 B2The Regents of the University of California
- Respiratory syncytial virus vaccine11 Oct 2022US 11,464,848 B2ModernaTX, Inc.
- Respiratory syncytial virus (RSV) replication inhibitors15 Sep 2020US 10,774,114 B2Fondation the Ark
- Stabilized antiviral fusion helices18 Sep 2018US 10,077,290 B2Dana-Farber Cancer Institute, Inc.
- Respiratory syncytial virus vaccine27 Mar 2025US 2025/0099569 A1ModernaTX, Inc.
- Simultaneous detection of antigens and antigen specific antibodies in a guinea pig model system27 Mar 2025US 2025/0102520 A1Vanderbilt University
- Conformational epitopes in respiratory syncytial virus g protein central conserved region9 May 2024US 2024/0150414 A1The Regents of the University of California
- Respiratory syncytial virus vaccine13 Apr 2023US 2023/0114180 A1ModernaTX, Inc.
- Respiratory syncytial virus vaccine30 Apr 2020US 2020/0129608 A1ModernaTX, Inc.
Most cited
By later US patents
- Respiratory syncytial virus vaccine43US 11,464,848 B2ModernaTX, Inc. · 2022
- Stabilized antiviral fusion helices3US 10,077,290 B2Dana-Farber Cancer Institute, Inc. · 2018
- Conformational epitopes in respiratory syncytial virus G protein central conserved region2US 11,773,143 B2The Regents of the University of California · 2023